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Abstract
Background: Diurnal fluctuation of bile acid (BA) concentrations in the enterohepatic system of mammals has been known
for a long time. Recently, BAs have been recognized as signaling molecules beyond their well-established roles in dietary
lipid absorption and cholesterol homeostasis.
Methods and Results: The current study depicted diurnal variations of individual BAs detected by ultra-performance liquid
chromatography/mass spectrometry (UPLC/MS) in serum and livers collected from C57BL/6 mice fed a regular chow or a
chow containing cholestyramine (resin). Circadian rhythms of mRNA of vital BA-related nuclear receptors, enzymes, and
transporters in livers and ilea were determined in control- and resin-fed mice, as well as in farnesoid X receptor (FXR) null
mice. The circadian profiles of BAs showed enhanced bacterial dehydroxylation during the fasting phase and efficient
hepatic reconjugation of BAs in the fed phase. The resin removed more than 90% of BAs with b-hydroxy groups, such as
muricholic acids and ursodeoxycholic acid, from serum and livers, but did not exert as significant influence on CA and CDCA
in both compartments. Both resin-fed and FXR-null mouse models indicate that BAs regulate their own biosynthesis
through the FXR-regulated ileal fibroblast growth factor 15. BA flux also influences the daily mRNA levels of multiple BA
transporters.
Conclusion: BA concentration and composition exhibit circadian variations in mouse liver and serum, which influences the
circadian rhythms of BA metabolizing genes in liver and ileum. The diurnal variations of BAs appear to serve as a signal that
coordinates daily nutrient metabolism in mammals.
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Introduction
Organisms have developed 24-hr (circadian) rhythmic physio-
logical processes to adapt to daily environmental changes. The
main circadian clock is situated in the suprachiasmatic nucleus in
the brain and synchronizes peripheral clocks. However, peripheral
tissues, like liver, can generate oscillations independent of the
suprachiasmatic nucleus [1]. A special group of clock genes,
organized in feedback loops, are responsible for the circadian
rhythms in both the suprachiasmatic nucleus and peripheral
organs. The phase of the suprachiasmatic nucleus neurons is
mainly entrained by the light-dark cycle, whereas that of
peripheral organs, like liver and intestine, is more influenced by
the feeding-fasting cycles [2]. Recently, clocks in peripheral tissues,
such as lung, were shown to be sensitive to temperature changes
within physiological range [3].
In the enterohepatic system, bile acids (BAs) play important
roles in eliminating cholesterol and solubilizing lipid nutrients [4].
Recently, BAs have been recognized as signaling molecules that
orchestrate the metabolism of BAs, glucose, fatty acid, and
lipoprotein synthesis through activating the nuclear receptor,
farnesoid X receptor (FXR) [5], and energy expenditure via a
membrane receptor, the G-protein-coupled receptor TGR5 [6].
Therefore, the diurnal variation of BA concentrations in livers and
serum may influence the daily energy homeostasis in mammals.
BAs undergo extensive recycling between liver and intestine,
which is termed the enterohepatic circulation (EHC) of BAs [4].
The EHC has two BA inputs, the biosynthesis of primary BAs
from cholesterol or oxysterols in the liver, and the formation of
secondary BAs from primary BAs by intestinal bacteria. Primary
BAs in humans are chenodeoxycholic acid (CDCA; 3a,7a-
dihydroxy) and cholic acid (CA; 3a,7a,12a-trihydroxy). In mice,
the CDCA-derived alpha-muricholic acid (aMCA; 3a,6b,7a-
trihydroxy) and beta-muricholic acid (bMCA; 3a,6b,7b-trihy-
droxy) [7], as well as CA are the predominant primary BAs. BAs
are mainly conjugated with taurine in mice before being excreted
into bile. Primary BAs that enter the intestinal lumen are
efficiently reabsorbed by the small intestine. A portion of the
primary BAs are deconjugated by bacteria in the distal ileum and
transformed into secondary BAs in the large intestine. Bacteria
convert CA into deoxycholic acid (DCA, 3a,12a-dihydroxy);
CDCA into lithocholic acid (LCA, 3a-monohydroxy) and
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hyocholic acid (HCA, 3a,6a,7a-trihydroxy) and murideoxycholic
acid (MDCA, 3a,6b-dihydroxy); and bMCA into omega-muri-
cholic acid (vMCA, 3a,6a,7b-trihydroxy) and hyodeoxycholic
acid (HDCA, 3a,6a-dihydroxy) [4,8].
Membrane transporters in liver and ileum ensure efficient EHC
of BAs (Fig. 1). In ileum, the apical sodium-dependent BA
transporter (Asbt) [9] and the basolateral heterodimeric organic
solute transporters alpha and beta (Osta/Ostb) [10] transport
most of the conjugated BAs from the intestinal lumen into the
portal vein. Unconjugated mono- and di-hydroxy BAs can
passively diffuse through enterocytes [4]. Hepatocytes remove
conjugated BAs from the portal venous blood by the sodium
taurocholate cotransporting polypeptide (Ntcp) [11] and uncon-
jugated BAs by basolateral transporters [12] such as organic anion
transporting peptide 1b2 [13] or passive diffusion. BAs are
excreted into canalicular bile via the ATP-energized bile salt
export pump (Bsep) and multidrug-resistant protein 2 (Mrp2) [12].
Under normal physiological conditions, the EHC of BAs is so
efficient that the newly synthesized BAs contribute less than 5% of
the circulating BAs in humans [4].
The circadian clock is known to regulate the expression of
several genes involved in BA metabolism, such as cytochrome
P450 7a1 (Cyp7a1) [14,15], the rate-limiting enzyme for BA
synthesis. Interestingly, the expression of Cyp7a1 is also sup-
pressed by FXR, which can be activated by BAs at physiological
concentrations [16,17]. Meanwhile, FXR regulates the expression
of multiple BA transporters [11,18,19,20]. Therefore, the food-
induced BA flux provides a diurnal activation of FXR, which
could, in turn, exert circadian regulations on its target genes.
The current study was designed to determine circadian rhythms
of individual BAs and the influence of BAs on the daily expression
of genes involved in BA metabolism in mice. To address these
issues, mice were fed cholestyramine, a polymeric BA-binding
resin, to interrupt the EHC of BAs, as well as FXR-null mice were
used to determine the regulatory roles of FXR on enterohepatic
gene expression. Insights into BA metabolism and roles of BA-




Mice were housed according to guidelines of the Institutional
Animal Care and Use Committee at the University of Kansas
Medical Center, and procedures were carried out in compliance
with standards for use of laboratory animals. Animal experiments
performed in this manuscript have been approved by the
Institutional Animal Care and Use Committee at the University
of Kansas Medical Center (protocols 2005–1504 and 2008–1725).
Animals and treatments
Male C57BL/6 mice (7 weeks of age) were purchased from
Charles River (Wilmington, MA). Age-matched FXR-null mice on
C57BL/6 background were bred in the animal facility at this
university. All mice were acclimated in a temperature/humidity
controlled facility with a 12-hr lighting schedule (05:00–17:00) for
one week, and fed either regular pellet rodent chow (Harlan
Teklad, Madison, WI) or ground chow supplemented with 2% (w/
w) cholestyramine (Sigma, St. Louis, MO) for another week. All
mice had ad libitum access to drinking water and feed. For resin-fed
groups, diet and cages were replaced daily. Serum, livers, and ilea
were collected from mice (n=5/time point for wild-type and
n=4/time point for FXR-null) at 4-hr intervals over 24 hr. The
first time point was 1 hr after the light was on. Livers and ilea were
rinsed with saline, frozen in liquid nitrogen, and stored at 280uC
until use.
Quantification of BAs in mouse serum and liver
BA concentrations in mouse liver and serum were quantified by
reverse-phase ultra-performance liquid chromatography-mass
spectrometry (UPLC-MS/MS). Detailed preparations of serum
and liver BA samples as well as internal standards were described
previously [21].
RNA extraction
Total liver and ileum RNA was prepared with RNA-Bee
reagent (Tel-Test Inc., Friendswood, TX) from frozen tissues
following the manufacturer’s instructions. RNA concentrations
were quantified with a Nanodrop nd-1000 spectrophotometer
(Thermo Scientific, Wilmington, DE) and diluted to a final
concentration of 1 mg/ml. Purified RNA was stored at 280uC.
Five (wild-type) or 4 (FXR-null) individual samples from each
group were used for gene expression assays.
Figure 1. Scheme of major components of the enterohepatic
circulation (EHC) of bile acids (BAs) in mice. Primary BAs are
synthesized and conjugated by the liver and released into the intestine
lumen to aid nutrient absorption. The majority of BAs are reabsorbed by
intestinal transporters Asbt (apical) and Osta/b (basolateral) into portal
venous blood. A small portion of BAs are deconjugated by bacteria in
distal ileum and further dehydroxylated or epimerized by bacteria in the
large intestine to generate secondary BAs. Deconjugated primary and
secondary BAs can be passively diffused into the portal blood. Ntcp is
the major transporter in the liver that removes the majority of BAs from
portal blood. Unconjugated BAs are taken up by organic anion
transporting polypeptide 1b2 (Oatp1b2) on the basolateral membrane
of hepatocytes or passive absorption. Upon entering hepatocytes,
unconjugated and secondary BAs are reconjugated and rehydroxylated
before they are pumped into the bile by Bsep to start another EHC.
Under normal conditions, BAs are synthesized in pericentral hepato-
cytes, whereas BAs are taken up by periportal hepatocytes. Nuclear
receptor FXR coordinates BA homeostasis by promoting (arrow) or
repressing (blunt arrow) of key BA synthesis enzymes or transporters in
liver and ileum. Bold arrows indicate the BA flows.
doi:10.1371/journal.pone.0016683.g001
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Messenger RNA of target genes were quantified using branched
DNA signal amplification assays (Affymetrix/Panomics, Inc.,
Fremont, CA) as reported previously [22]. The bDNA probe sets
have been published [22,23,24,25]. Ten mg of RNA was used for
the assay and luminescence was quantified with a Synergy 2 Multi-
Detection Microplate Reader interfaced with Gen5 Reader
Control and Data Analysis Software (Biotek, Winoosky, VT).
Luminescence was reported as relative light units (RLU) per 10 mg
of total RNA.
Statistical analysis
Data are presented as mean 6 standard error of the mean (n=5
or 4). Statistical differences between groups at each time point
were analyzed using a student t-test (two tailed) and significance
level was set at p,0.05.
Results
Circadian rhythms of serum BAs in control- and resin-fed
mice
In control mice, total serum BA concentrations were lowest in
the middle of the light phase (0.9 nmol/ml at 10:00), and highest
in the beginning and end of the dark phase (2.9 nmol/ml at 18:00
and 02:00) (Fig. 2). About 75% of serum BAs are primary BAs,
which exhibited a similar circadian pattern as total BAs.
Secondary BAs had a pronounced circadian peak at 18:00. The
major serum BAs were taurine-conjugated BAs (more than 93% in
the dark phase), followed by unconjugated BAs. Glycine-
conjugated BAs were minor components (0.7 to 4.1% during the
day). Serum contained the highest percentage of unconjugated
BAs at 14:00 (33.8%) and the lowest at 02:00 (3.8%).
Consuming the resin-containing diet resulted in flattened
diurnal peaks of total, primary, tauro-conjugated, and glyco-
conjugated BAs in mouse serum, but increased concentrations of
secondary and unconjugated BAs (Fig. 2). Peak serum concentra-
tions of secondary BAs and unconjugated BAs shifted from 18:00
and 14:00 in control mice, respectively, to 10:00 in mice fed the
resin diet.
Individual BAs exhibited distinct circadian rhythms in serum of
mice fed a control diet (Fig. 3). CA (41%) and bMCA (26%) were
predominant primary BAs in mouse serum, and both exhibited
similar circadian variations as that of total serum BAs described
above. CDCA concentrations in mouse serum were low during
most of the day and highest at 02:00. Concentrations of aMCA
had two small peaks at 14:00 and 02:00.
Under control feeding conditions, DCA and vMCA were the
major secondary BAs in mouse serum (Fig. 3). DCA, which was
1.2 to 10% of the total serum BAs, had a concentration peak at
18:00. LCA concentrations were very low but somewhat higher
during the late-light phase (10:00–18:00). Concentrations of
UDCA, which was about 4.5% of total serum BAs, were higher
in the dark phase and lower in the late-light phase. Serum
concentrations of MDCA were also very low, with the highest
concentrations at 18:00 and 02:00. vMCA, the most abundant
secondary BA in mouse serum, exhibited two identical peaks at
18:00 and 02:00, and a major trough at 10:00. HDCA had similar
circadian peak-and-trough times as did vMCA, but at much lower
concentrations.
The resin diet decreased the concentrations of aMCA, bMCA,
vMCA, and UDCA by 92, 99, 96, and 88% respectively, in mouse
serum (Fig. 3). MCAs (a, b, v) were reduced the most in resin-fed
mice during both fasting (10:00) and feeding (22:00) phases. The
contribution of MCAs to the total serum BAs decreased from 39%
in control-fed mice to 4% in resin-fed mice at 10:00 (Fig. 4). The
circadian variations of CA, MDCA, and HDCA in mouse serum
were flattened by the resin diet. In contrast, the resin diet increased
the daily average concentration of DCA 433%, with a pronounced
peak at 10:00; CDCA 75%, with higher concentrations from 02:00
to 10:00; and LCA 494%, with two identical peaks at 18:00 and
02:00. The resin diet increased DCA concentration the most (8.2
fold at 10:00 and 37.4 fold at 22:00), and its percentage of serum
total BAs increased from 8% in control mice to 51% in resin-fed
mice at 10:00 (Fig. 4).
Figure 2. Circadian fluctuations of serum total BAs, as well as secondary transformation and conjugations in control-fed (Ctrl) and
cholestyramine-fed (Resin) mice. Tauro-BAs: tauro-conjugated BAs; Glyco-BAs: glycine-conjugated BAs; Unconj-BAs: unconjugated BAs. Shaded
area of the figure represents dark phase and opened area stands for light phase. Data are presented as mean 6 standard error (n=5). Asterisk stands
for statistically difference between control and resin groups. p#0.05, student t-test (two-tailed). Same illustrations apply to the following figures.
doi:10.1371/journal.pone.0016683.g002
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both taurine-conjugated and unconjugated forms.
doi:10.1371/journal.pone.0016683.g003
Figure 4. Changes of BA composition in mouse serum by cholestyramine in the morning (10:00) and evening (22:00). Each individual
BA includes both taurine-conjugated and unconjugated forms.
doi:10.1371/journal.pone.0016683.g004
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mice
Liver BA concentrations in control-fed mice were higher in the
dark/feeding phase (Fig. 5). The highest BA concentration in liver
was 204 nmol/g at 02:00, and the lowest was 117 nmol/g at
14:00. Primary BAs, 79 to 87% of total BAs in the liver, exhibited
similar daily fluctuations as the total BAs. Concentrations of
secondary BAs, ranged from 24 to 35 nmol/g liver, did not show a
significant circadian pattern. About 75% of the BAs in mouse liver
were conjugated with taurine, approximately 24% unconjugated,
whereas only about 0.2% was conjugated with glycine. The
concentrations of conjugated BAs were higher in the dark phase,
whereas unconjugated BAs had a pronounced circadian peak at
18:00, and then gradually decreased during the remaining dark
phase.
Circadian peaks of BAs in mouse livers were flattened by the
resin diet (Fig. 5). In livers of resin-fed mice, the daily average total
BA concentration was 76 nmol/g, which was 53% less than in the
control diet-fed mice. The daily average concentrations of
primary, secondary, tauro-conjugated, glycine-conjugated, and
unconjugated BAs in resin-fed mouse livers were 52, 55, 41, 21,
and 88%, respectively, less than those in control diet-fed mice.
Individual BAs in livers of mice on the control diet exhibited
diurnal fluctuations (Fig. 6). In liver samples, concentrations of
aMCA and bMCA were shown as a combination (a-bMCAs)
because their peaks on UPLC-MS/MS chromatograms merged.
Primary BAs, including CA (51–80 nmol/g), CDCA (1.7–
3.5 nmol/g), and a-bMCAs (40–89 nmol/g) were higher during
the dark phase and lowest at the end of the light phase (14:00).
Similar to that in serum, vMCA and DCA were the
predominant secondary BAs in mouse livers. DCA concentrations
were high from 10:00 to 18:00, and low during the rest of the dark
phase. LCA concentrations were very low in mouse livers. The
hepatic concentrations of UDCA varied from 1.8 (14:00) to
3.3 nmol/g (02:00). MDCA exhibited similar circadian variations
as UDCA, with the highest concentration (,1.2 nmol/g) during
the late-dark phase. HCA concentration was low in livers, but was
relatively high during the early-light phase. The daily average
concentration of vMCA was 15.1 nmol/g liver, with the highest at
02:00. HDCA concentration was lowest at 22:00, and highest at
02:00 and 06:00.
Feeding the resin diet decreased more than 91% of MCAs (a, b,
and v) and UDCA, 59% of HCA, and 64% HDCA, but increased
DCA (376%), LCA (813%), and MDCA (62%) in mouse livers
(Fig. 6). Comparisons were made on the average daily concentra-
tion of each BA. The concentrations of DCA and LCA were
highest at 18:00 and lowest at 22:00. The daily average
concentration of CA and CDCA was similar in livers of control-
and resin-fed mice, except their circadian patterns were slightly
changed. MDCA had similar circadian patterns in the two groups
of mice, but at higher concentrations in livers of resin-fed mice.
Concentrations of HCA and HDCA were both highest at 10:00
and lowest at 22:00 in livers of resin-fed mice.
The resin diet altered BA profiles in livers of mice during fasting
(10:00) and feeding (22:00) phases (Fig. 7). The dramatic decrease
of MCAs by the resin-containing diet resulted in CA being the
only predominant primary BA, whereas the CA-derived DCA was
the major secondary BA in livers of resin-fed mice.
Effects of resin on daily mRNA profiles of genes encoding
key proteins involved in the EHC of BAs
In control diet-fed mice, FXR mRNA was evenly expressed
throughout the 24-hr time course in both livers and ilea (Fig. 8A).
The resin diet doubled the FXR mRNA content in liver, and
increased it 65% in ileum. Furthermore, a pronounced circadian
pattern of FXR mRNA was shown in both liver and ileum, with a
peak at 14:00.
In livers of control-fed mice, Shp mRNA was highest at 10:00 in
the morning and lowest at 22:00 in the evening (Fig. 8B). Cyp7a1
mRNA increased rapidly to the highest level after the onset of the
Figure 5. Circadian fluctuations of liver total BAs, as well as secondary transformation and conjugations in control- and resin-fed
mice.
doi:10.1371/journal.pone.0016683.g005
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level at 10:00. The resin diet did not influence the expression of
Shp, but increased the daily average of Cyp7a1 mRNA 285%,
without changing its circadian pattern. In control mice, mRNA of
the BA-uptake transporter, Ntcp, was relatively lower in the early
morning, and mRNA of the efflux transporter, Bsep, was slightly
Figure 6. Diurnal fluctuations of individual BAs in mouse liver under control- or resin-fed conditions. Each individual BA includes both
taurine-conjugated and unconjugated forms.
doi:10.1371/journal.pone.0016683.g006
Figure 7. Changes of BA composition in mouse serum by cholestyramine in the morning (10:00) and evening (22:00). Each individual
BA includes both taurine-conjugated and unconjugated forms.
doi:10.1371/journal.pone.0016683.g007
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significant diurnal variations. Consumption of the resin diet
increased mRNAs of Ntcp (130% daily average) and Bsep (49%
daily average) in mouse livers.
In ilea (Fig. 8C), mRNA of fibroblast growth factor 15 (Fgf15)
exhibited pronounced circadian rhythm with a major peak at
22:00 and a minor peak at 10:00. The resin diet reduced Fgf15
mRNA by 95% and eliminated its diurnal fluctuations. Messenger
RNA of the ileal BA-uptake transporter, Asbt, reached its highest
level at 18:00 and decreased to the lowest at 06:00 in regular-fed
mice. The resin diet increased Asbt mRNA during the light phase.
The mRNA of Osta, half of the ileal BA basolateral efflux
heterodimer, had a single peak at 18:00 in control mice. In mice
fed the resin diet, Osta mRNA levels were comparable to control
mice, but had a peak at 14:00. The apical efflux transporter Mrp2
showed a marked diurnal mRNA peak at 18:00 in control mice,
and the resin diet decreased it 62.5%.
Circadian expression of key BA metabolism genes in FXR-
null mice
To further clarify the role of FXR in regulating the circadian
rhythm of BA-related genes, livers and ilea were collected from
FXR-null mice from 10:00 to 22:00. In livers, FXR-null mice had
53% less Shp mRNA and 135% more Cyp7a1 mRNA than did
WT mice, but the circadian patterns of both genes remained the
same (Fig. 9). In ilea of FXR-null mice, the daily levels of Fgf15
mRNA and Osta mRNA were 79 and 57% lower than in WT
mice, respectively. The circadian rhythms of Fgf15 and Osta
observed in WT mice disappeared in FXR-null mice.
Discussion
The present study depicts the circadian rhythm of BA
composition during a 24-hr feeding/fasting cycle in mice. This
enables us to speculate about potential metabolic pathways for
BAs and discuss the influence of BAs, through their sensor FXR,
on the circadian rhythm of enterohepatic genes encoding key
proteins involved in BA biosynthesis and transport.
Diurnal variation of BA concentrations in serum and liver are in
phase with the fasting/feeding cycle of mice. The total BA
concentrations in liver and serum are lowest towards the end of the
light/fasting phase (Figs. 2 and 4) when BAs are stored in the
gallbladder and intestinal lumen. When mice start eating, more
BAs enter the intestine lumen and intestinal absorption of BAs is
accelerated, leading to increased BA concentrations in serum and
liver. The two BA peaks in serum suggest that mice have two
episodes of food ingestion in the dark phase, mimicking the
postprandial increase of serum BAs in humans [26]. The gradual
increase of liver BA concentrations during the dark phase could be
the result of rapid EHC and active BA biosynthesis.
The conjugation/deconjugation of BAs exhibits a diurnal
rhythm in mice. There is an increase in unconjugated BAs in
serum during the light phase (Fig. 2), suggesting active deconjuga-
tion of BAs by the intestinal bacteria when mice are fasting. Livers
receive the highest amount of unconjugated BAs at the beginning
of the active/dark phase (Fig. 5), and efficiently reconjugate them
with taurine. By the end of the dark phase, unconjugated BA
concentrations decrease to low levels in both serum and liver.
The conversion between primary and secondary BAs are
catalyzed by enzymes synthesized by intestinal bacteria or
enzymes in the liver [4]. It is interesting that the diurnal rhythm
of DCA in mouse serum is divergent from its precursor CA,
whereas the circadian fluctuation of vMCA is in phase with its
precursor bMCA. One potential explanation is that bacteria
Figure 8. Circadian expression of hepatic and ileal genes in
control- and resin-fed mice. (A) Circadian expression profiles of FXR
in liver and Ileum, (B) hepatic genes, and (C) ileal genes under control-
and resin-fed conditions.
doi:10.1371/journal.pone.0016683.g008
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and epimerization (bMCA into vMCA, and CDCA into UDCA)
of BAs have different activity, population size, and localization in
the intestinal tract. They might have different reactions to food
ingestion. It could also be because hepatic enzymes that re-
hydroxylate or epimerize secondary BAs back into primary BAs
have different activities during the 24-hr cycle. Another possibility
is that intestinal transporters like Asbt absorb CA more efficiently
than bMCA during food digestion, which protects CA from the
bacterial transformation. However, these hypotheses need to be
tested before firm conclusions can be made.
The circadian rhythm of BAs has been long recognized
[27,28,29]. However, the circadian rhythm of BA metabolizing
genes has not been thoroughly investigated. FXR is the key factor
that regulates a broad range of genes encoding BA enzymes and
transporters in liver and ileum (Fig. 1). In control-fed mice, FXR
mRNA did not have a predominant diurnal rhythm in either
organ. However, the resin diet markedly increased FXR mRNA
and produced a circadian peak in both liver and ileum, indicating
FXR might be negatively regulated by BAs.
Although both circadian clock and BA-FXR signaling are well
established in regulating Cyp7a1 transcription, little is known
about the influence of diurnal variation of BAs on Cyp7a1
expression. FXR negatively regulates the transcription of Cyp7a1
via Shp in liver [30] and Fgf15 from ileum [31]. The circadian
rhythm of Shp mRNA is regulated by the clock gene Rev-erba
[15], and is not changed by either resin diet or FXR deficiency in
mouse livers (Figs. 6 and 7). Fgf15 mRNA peaks 4-hr after that of
Cyp7a1 (Fig. 8), suggesting Fgf15 contributes to the decline of liver
BA biosynthesis in the late-dark phase. Similar postprandial peaks
were previously observed in circulating Fgf19, the human homolog
of Fgf15 [32]. The circadian expression of Fgf15 appears to
depend on the activation of intestinal FXR by BAs. In resin-fed or
FXR-null mice, the diminished Fgf15 signal releases the repression
on Cyp7a1, leading to higher transcription of Cyp7a1 in livers.
However, the circadian rhythm of Cyp7a1 is not changed in either
model, suggesting the rhythmic regulation from the clock genes
[14,15]. Moreover, the FXR-dependent regulation of Fgf15 was
also demonstrated in FXR ileum-specific null mice [33]. Taken
together, BAs regulate Cyp7a1 mRNA through the ileal FXR-
Fgf15 signaling pathway, but the circadian rhythm of Cyp7a1 is
determined by clock genes.
In mice, the hepatic enzymes that convert CDCA into a- and b-
MCA remain unknown. Compared to the relatively consistent
concentration of CA, concentrations of aMCA and bMCA exhibit
more profound diurnal fluctuations in mouse livers. Because
Cyp7a1 initiates the biosynthesis of both CDCA and CA, the
activity of enzymes transforming CDCA into a- and b-MCA is
likely to have circadian variations.
Enhanced ileal transport upon food ingestion facilitates
reabsorption of BAs from the intestine lumen back into serum
and liver. This is supported by the increased mRNAs of ileal BA
uptake transporter Asbt and efflux transporter Osta at the
beginning of the dark phase (Fig. 8).
FXR has been reported to regulate multiple BA transporters. In
mice, the activation of FXR indirectly represses the expression of
Ntcp in liver [11] and Asbt in ileum [18], and directly promotes
the expression of Bsep in hepatocytes [19] and Osta/b in ileocytes
[20]. When cholestyramine is fed, the BA flux is decreased, leading
to diminished activation of FXR in both liver and ileum.
Accordingly, more Asbt is expressed in ileum to enhance the
absorption of BAs in the ileum. Meanwhile, hepatocytes express
more Ntcp to enhance the extraction of BAs from portal blood.
Osta mRNA is not decreased by BA deprivation, but is ablated in
FXR-null mice, suggesting FXR regulates Osta expression
independent of BAs. Changed circadian expression profiles of
Ntcp and Bsep were previously reported in mice either on a 2%
cholestyramine diet or deficient in FXR under restricted feeding
Figure 9. Comparing mRNAs of key hepatic and ileal BA-metabolism genes from 10:00 to 22:00 in wild-type (WT; n=5) and FXR-null
(n=4) mice. Asterisk stands for statistically difference between wild-type and FXR-null.
doi:10.1371/journal.pone.0016683.g009
Circadian Rhythm of Bile Acids
PLoS ONE | www.plosone.org 8 February 2011 | Volume 6 | Issue 2 | e16683[34]. Mrp2 locates on the apical membrane of enterocytes and
effluxes organic anions back into the intestinal lumen [35]. The
transcription of Mrp2 is positively regulated by FXR [36]. The
sequestration of BAs also reduced the mRNA expression of Mrp2
in ileum. Hence, BAs may diurnally influence the transcription of
enterohepatic transporters through FXR.
The primary BAs decreased the most in mice by cholestyramine
were a- and b-MCA, with less of a decrease of CA. Similarly,
humans treated with another BA binding resin, colesevelam, had
decreased CDCA but increased CA pool sizes [37]. The synthesis
of conjugated CDCA and the subsequent transformation into
MCAs were shown to be increased in hepatocytes isolated from
rats fed cholestyramine [38]. Therefore, the removal of MCAs
from the enterohepatic system of mice (CDCA in humans), which
in turn promotes the biosynthesis of BAs from cholesterol in the
liver, appears to be the major mechanism for the cholesterol-
lowering effect of BA resins.
Omega MCA is a major secondary BA in mice. Both the
current study and a previous study [21] observed markedly
reduced concentrations of vMCA in mouse livers after cholestyr-
amine treatment. DCA concentration is increased in the resin-
treated mice in the current study, but was unchanged in the
previous report [21]. Taken together, cholestyramine decreased
BAs having b-hydroxy groups, such as aMCA (6b-OH), bMCA
(7b-OH), vMCA (7b-OH), and UDCA (7b-OH), more than other
BAs in mice (Fig. 3 and 6). Direct binding assays are required to
determine whether this is due to differences in binding affinities. In
addition to hepatic BA biosynthesis and cholestyramine-binding
affinity, changes of intestinal microflora can also influence the bile
acid profile in cholestyramine-fed mice.
In summary, the EHC of BAs has a predominant circadian
rhythm that is in phase with the feeding/fasting cycle of mice. The
diurnal variations of BA concentrations and composition could
play important roles in coordinating nutrient absorption and
energy homeostasis. FXR, in respond to daily BA fluctuations
upon food ingestion, determines the basal and circadian
expression of Fgf15, and regulates vital enzymes and transporters
in mouse liver and ileum to maintain BA homeostasis.
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